Form 4: PAVmed Inc. Director Sundeep Agrawal Acquires 205,000 Employee Stock Options
SEC Form 4 Filing
Director Sundeep Agrawal reports acquisition of 205,000 employee stock options in PAVmed Inc.
Summary
- On September 19, 2024, Sundeep Agrawal, a director of PAVmed Inc., acquired 205,000 employee stock options.
- The exercise price of these options is $1.63.
- One third of the options vest on June 30, 2025, with the remainder vesting in eight equal quarterly installments starting September 30, 2025.
- The options expire on September 19, 2034.
- Following the transaction, Agrawal directly owns 205,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. While insider ownership can be a positive signal, this is a routine grant.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/19/2024 | Date of transaction: Sundeep Agrawal acquired 205,000 employee stock options. |
| 06/30/2025 | One third of the options vest. |
| 09/30/2025 | The balance of the options vests in eight equal quarterly installments, starting on this date. |
| 09/19/2034 | Expiration date of the employee stock options. |
Keywords
PAVmed Inc., Sundeep Agrawal, stock options, Form 4, director, acquisition, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.